Soft Tissue Allografts Market
The soft tissue allografts market report emphasizes the trends prevalent in the global market, along with drivers and deterrents affecting its growth.
Soft Tissue Allografts Market Analysis
Increasing aging population and the rising incidence of sports injuries & trauma are contributing to the growing soft tissue allografts market size. However, the high cost of procedures hampers the soft tissue allografts market growth. Further, development of customized grafts is expected to bring in new soft tissue allografts market trends in the coming years.
Development of Customized Grafts to Bring New Trends in Soft Tissue Allografts Market During Forecast Period
Customizing grafts to suit the specific needs of a patient, such as matching tissue characteristics, could improve the success rate of soft tissue reconstruction surgeries and reduce the risk of rejection. Each patient has unique anatomical and physiological features that influence a graft’s acceptance inside their body. Customizing allografts involves selecting or altering grafts to match the size, shape, cellular composition, and biological characteristics of the recipient’s tissues. Companies operating in this market are offering customized solutions. For instance, ZimVie Inc. offers Puros Allograft Customized Blocks, which represents a significant advancement in block grafting. Using CAD/CAM technology, a custom block is created based on a CBCT/CT scan of the affected area. The block grafting approach enhances patient comfort by shortening surgery time and reducing the likelihood of complications. ROKIT HEALTHCARE (South Korea) is another biotechnology company offering hyper-personalized organ regenerative healthcare solutions. Further, Canada-based Sinai Health’s Allograft Technologies (MSAT) Department is renowned for its advanced tissue innovations. The department offers bone and tissue allograft products and works closely with healthcare providers to provide customized solutions. Thus, customized grafts are likely to emerge as significant trends in the soft tissue allografts market in the coming years.
Soft Tissue Allografts Market Report Scope:
The geographic scope of the soft tissue allografts market report covers North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), South & Central America (Brazil, Argentina, and Rest of South & Central America), and the Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa). . In terms of revenue, North America dominated the market in 2024. It is estimated to dominate the global market during the forecast period. Sports injuries often lead to ailments such as joint pain, stiffness, and swelling. As per the data published by Johns Hopkins, there has been a significant rise in the number of participants in organized sports activities over the years. Approximately 30 million children and adolescents participate in youth sports in the country, leading to an increase in the number of sports injuries among young athletes, with over 3.5 million injuries reported yearly. Almost one-third of all injuries that occur in childhood are caused by sports. According to the National Safety Council (NSC), biking caused 426,000 injuries in 2020, the most of any sport or recreational activity, while exercises (with or without equipment) ranked second with ~378,000 injuries. These factors were followed by off-highway vehicles (OHVs, including mopeds and minibikes) with 230,000 injuries, and skateboards, scooters, and hoverboards with 218,000 injuries. Sports-related injuries often involve damage to soft tissues such as muscles, tendons, and ligaments. These injuries range from strains and sprains to more severe conditions such as tears or ruptures. In some cases, when the injury is too extensive for the body to heal on its own, soft tissue allografts are used to repair or reconstruct the damaged tissue. These allografts are particularly useful for repairing ligaments, tendons, or cartilages that are too damaged to treat via other methods such as sutures or autografts (using patient’s self-tissue).
The US represents a significant portion of the soft tissue allografts market, with a notable number of procedures performed annually. According to a study titled “New Device Inspired by Python Teeth Doubles Strength of Rotator Cuff,” published in 2024, more than 600,000 rotator cuff procedures are performed yearly in the US. As per the American Orthopedic Society for Sports Medicine, nearly 100,000 to 250,000 ACL ruptures are reported in the country annually. Several tissue injuries have received significant importance, increasing awareness about soft tissue injuries and their treatment among athletes.
Furthermore, in May 2023, AlloSource announced the introduction of AlloMend Duo Acellular Dermal Matrix (ADM), a natural solution designed for soft tissue reconstruction. It is one of the largest nonprofit providers of allografts in the US, known for developing innovative cellular and tissue products to aid surgeons in healing their patients. ADM was developed to assist surgeons in repairing and reconstructing soft tissue defects, offering long-term structural support. This deep reticular dermal allograft integrates with the surrounding tissue, serving as a scaffold that encourages cell repopulation and regeneration of natural host tissues. Its flexible and pliable characteristics make it ideal for various medical procedures that demand strength and biocompatibility in a human regenerative tissue matrix, allowing for precision placement and optimal handling.
Companies operating in the soft tissue allografts market constantly focus on strategic developments such as product approvals, collaborations, funding, agreements, and new product launches, which help them improve their sales, increase their geographic reach, and reinforce their capacities to cater to a greater than existing customer base. A few strategic initiatives by key players operating in the soft tissue allografts market are mentioned below.
• In January 2025, Zimmer Biomet announced a definitive agreement to acquire all outstanding shares of Paragon 28, a company specializing in foot and ankle orthopedic solutions. The acquisition, valued at approximately US$ 1.1 billion, is expected to strengthen Zimmer Biomet’s position in the foot and ankle segment, which is a high-growth area within musculoskeletal care.
• In February 2024, Smith+Nephew unveiled an expanded Sports Medicine portfolio at the AAOS Annual Meeting, featuring products like the REGENETEN Bioinductive Implant. This implant serves as a ‘scaffold’ for new tendon-like tissue growth, increasing tendon thickness and improving healing outcomes for rotator cuff tears.
• In July 2024, Dentsply Sirona updated its Symbios Allograft product line to emphasize enhanced sterility and versatility. The enhanced Symbios Allograft line offers both mineralized and demineralized regenerative solutions, tailored for various dental surgery and implant needs. These products are designed to promote bone formation, increase volume, and ensure stability for predictable, long-term outcomes. The updated portfolio features new granule allografts, putty products, and the acellular dermal matrix known as Symbios PerioDerm.
• In January 2023, Zimmer Biomet Holdings, Inc. announced that it has reached a definitive agreement to acquire Embody, Inc., a privately-held medical device company focused on soft tissue healing, for US$ 155 million at closing and up to an additional US$ 120 million subject to achieving future regulatory and commercial milestones over a three-year period.
• In June 2023, Stryker announced the acquisition of Artelon, a company specializing in innovative soft tissue fixation products for foot and ankle and sports medicine procedures. This acquisition aims to enhance Stryker’s offerings in the soft tissue fixation segment, providing differentiated solutions for ligament and tendon reconstruction.
Therefore, ongoing funding, product launches and approvals, and collaborations are expected to create ample opportunities for the growth of the soft tissue allografts market in the coming years.
The soft tissue allografts market analysis has been carried out by considering the following segments: type, application, end user, and geography.
- Based on type, the soft tissue allografts market is segmented into cartilage allograft, tendon allograft, dental allograft, meniscus allografts, placental tissue, and others. The cartilage allograft segment held the largest share of the market in 2024.
- In terms of application, the soft tissue allografts market is categorized into orthopedic, dentistry, wound care, and others. The orthopedic segment dominated the market in 2024.
- In terms of end user, the soft tissue allografts market is categorized into hospitals, specialty clinics, and others. The hospitals segment dominated the market in 2024.
Soft Tissue Allografts Market: Competitive Landscape and Key Developments
Zimmer Biomet Holdings Inc, Conmed Corp, Stryker Corp, Smith & Nephew Plc, Integra LifeSciences Holdings Corp, Arthrex Inc, AbbVie Inc, Organogenesis Inc., Dentsply Sirona Inc, and Axogen Corporation are among the prominent players profiled in the soft tissue allografts market report. In addition, several other players have been studied and analyzed during the study to get a holistic view of the market and its ecosystem. These companies focus on geographic expansions and new product launches to meet the increasing demand from consumers worldwide and diversify their product range in specialty portfolios. Their global presence allows them to serve a large customer base, subsequently facilitating market expansion.
